Correct Answer: C. Biliary atresia
Biliary atresia (BA) is the leading indication for liver transplantation in children worldwide and in India. It is a progressive fibro-obliterative disease of the extrahepatic and intrahepatic bile ducts presenting in neonates with persistent cholestasis (direct hyperbilirubinaemia >2 mg/dL beyond 2 weeks of life). The disease leads to cirrhosis and end-stage liver disease (ESLD) by 2–5 years if untreated. The Kasai portoenterostomy (hepatoportoenterostomy) is the first-line surgical intervention in infants <90 days old, but only 40–50% achieve long-term native liver survival; the remainder progress to ESLD requiring transplantation. In India, BA accounts for approximately 40–50% of pediatric liver transplant indications at major centres (AIIMS, CMC Vellore). The disease is idiopathic but associated with splenic anomalies (heterotaxy, asplenia) in ~10% of cases. Early diagnosis via hepatobiliary ultrasound, hepatobiliary scintigraphy, and intraoperative cholangiography, followed by timely Kasai surgery or transplantation, is critical. Children with BA who fail Kasai or present late develop portal hypertension, coagulopathy, and hepatic encephalopathy, making transplantation life-saving. The 5-year survival post-transplant in BA exceeds 80% in developed centres and is improving in India.
Why the other options are wrong
A. Hepatocellular carcinoma — HCC is rare in children and is not a common indication for pediatric liver transplantation in India. HCC typically arises in cirrhotic livers (e.g., from chronic hepatitis B in endemic regions), but the absolute number of children with HCC is very low. Adult HCC (often from HBV/HCV) is the leading transplant indication in adults in India, but pediatric HCC is uncommon. This is an age-specific trap—NBE conflates adult and pediatric indications. B. Caroli disease — Caroli disease (congenital communicating cavernous ectasia of intrahepatic bile ducts) is a rare autosomal recessive disorder causing recurrent cholangitis, bile stasis, and increased cholangiocarcinoma risk. While it may eventually require transplantation, it is far less common than biliary atresia in the pediatric population. Caroli disease is often managed medically (antibiotics, ursodeoxycholic acid) for years before ESLD develops. NBE may include this as a distractor because it is a rare, 'exotic' biliary disease. D. Alagille syndrome — Alagille syndrome (ALGS) is an autosomal dominant disorder (JAG1 or NOTCH2 mutations) characterized by cholestasis, cardiac defects, skeletal abnormalities, and characteristic facies. While some ALGS patients develop progressive liver disease and may require transplantation, most have mild-to-moderate cholestasis that stabilizes. ALGS is far less common than BA and accounts for <5% of pediatric transplant indications. The trap: ALGS is a 'syndromic' biliary disease, but its prevalence and transplant requirement are much lower than BA.
High-Yield Facts
- Biliary atresia is the leading indication for pediatric liver transplantation globally and in India (~40–50% of cases).
- Kasai portoenterostomy (hepatoportoenterostomy) is the first-line surgery in infants <90 days old; 40–50% achieve long-term native liver survival.
- Progressive cholestasis (direct bilirubin >2 mg/dL beyond 2 weeks) and cirrhosis by age 2–5 years drive the need for transplantation in BA.
- Splenic anomalies (heterotaxy, asplenia) are associated with BA in ~10% of cases (embryologic link).
- 5-year post-transplant survival in BA exceeds 80% in major Indian centres; early diagnosis and timely intervention are critical.
Mnemonics
BA = Biggest in pediatric Tx Biliary Atresia = Biggest indication for pediatric liver transplantation. Remember: BA is the #1 reason children need a new liver in India. KASAI saves some, Tx saves all KASAI (Kasai portoenterostomy) works in 50%, so the other 50% need Tx (transplantation). If Kasai fails or BA is diagnosed late, transplantation is definitive.
NBE Trap
NBE conflates adult and pediatric transplant indications—HCC is the leading indication in adults (especially in HBV-endemic India), but in children, biliary atresia dominates. The question tests whether students know the age-specific epidemiology of transplant indications.
Clinical Pearl
In Indian pediatric practice, a neonate presenting with persistent jaundice beyond 2 weeks, acholic (pale) stools, and hepatomegaly should raise suspicion for biliary atresia. Early referral to a transplant centre (AIIMS, CMC, SGPGI) for Kasai surgery or transplant evaluation within the first 90 days of life is critical—delays beyond this window reduce Kasai success and increase the urgency of transplantation.
_Reference: OP Ghai Essentials of Pediatrics, Ch. Hepatobiliary Disorders; Harrison Principles of Internal Medicine, Ch. 297 (Liver Transplantation)_